News
INITIO updates and comments on new studies
‘Next big wave’: Radiation drugs track and kill cancer cells
Dr. Rob’s comment: Targeted radiotherapy is the process of making a drug that can lock onto a cancer cell, and then adding a radioactive atom to that drug. After we inject the material, it locks onto cancer cells, and highly targeted radioactive emissions kill the cancer cells, while sparing healthy tissue. This treatment, which has been available in Europe, Australia and the US, is now coming to clinical trials in Canada, and INITIO is excited to participate in these trials, currently in planning stages for prostate cancer, and slated to begin later this summer.
PET shows potential at detecting neuroedocrine cancer
A new PET tracer, uPAR, is able to detect the functional activity of these tumours, allowing them to be more easily diagnosed and therefore referred for better treatment earlier. It can also aid physicians in determining who is at greater risk of disease progression.
PET/CT predicts survival outcomes in immunotherapy patients
Article: https://www.auntminnie.com/index.aspx?sec=sup&sub=mol&pag=dis&itemId=134558 In this study of 51 patients with melanoma on immunotherapy, the results of a PET/CT scan with the radiolabeled sugar molecule FDG, within
AI vs Alzheimer’s
Article: AI gets $20M infusion to go on the offensive against Alzheimer’s Alzheimer’s Disease is, at present, an unstoppable disease which attacks memory, language, and
Playing video games may help reduce dementia risk
Article: Playing Video Games for 30 Minutes a Day Effective Against Dementia in Older Adults, Study Finds We are constantly learning what treatments are and
First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms
Nuclear medicine has entered an era when we are discovering more and more molecules which can precisely target cancer cells. In this case, the molecule
